Europe Startup Funding Rounds
Startups raising capital across Europe. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 1,357 Jan 1 – Oct 11, 2026
- Disclosed funding
- $60.9B 1151 disclosed amounts
- Median round
- $6.8M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| F FineHeartCompany profile Develops cardiology devices, including the fully implantable FlowMaker system. Develops cardiology devices, including the fully implantable FlowMaker system. | €83M | Series CSeries C+ | Healthtech | France | Investors | |
| T TucuviCompany profile Tucuvi provides conversational AI for clinical patient follow-up and monitoring. Tucuvi provides conversational AI for clinical patient follow-up and monitoring. | $20M | Series A | AI | Spain | Investors | |
| A AliceCompany profile Alice is an AI workspace for litigation teams, connecting case-file analysis, legal research, argument building and drafting. Alice is an AI workspace for litigation teams, connecting case-file analysis, legal research, argument building and drafting. | €1M | Pre-SeedPre-seed | Enterprise software | Belgium | Investors | |
| LO Lookiero Outfittery GroupCompany profile Lookiero Outfittery Group offers personalized fashion recommendations through a platform with AI-driven features. Lookiero Outfittery Group offers personalized fashion recommendations through a platform with AI-driven features. | €17M | Undisclosed | Ecommerce | Spain | Investors | |
| V Develops and manufactures insulin patch pump systems for diabetes management | $13M | Series DSeries C+ | Healthtech | Netherlands | Investors | |
| A AbbelightCompany profile Microscopy and nanoscopy systems combining chemistry, optics and analysis for life-science researchers. Microscopy and nanoscopy systems combining chemistry, optics and analysis for life-science researchers. | Undisclosed | Series B | Biotech | France | Investors | |
| ET Enodia TherapeuticsCompany profile Develops small-molecule therapies for targeted protein degradation at the point of synthesis Develops small-molecule therapies for targeted protein degradation at the point of synthesis | €20.7M | Seed | Biotech | France | Investors | |
| B BrightHeartCompany profile BrightHeart develops AI software for prenatal ultrasound and fetal-heart screening. BrightHeart develops AI software for prenatal ultrasound and fetal-heart screening. | €11M | Series A | AI | France | Investors | |
| PD Perceptive DiscoveryCompany profile Provides preclinical and translational solutions for oncology and radiopharmaceutical programs Provides preclinical and translational solutions for oncology and radiopharmaceutical programs | $15M | StrategicUndisclosed | Biotech | United Kingdom | Investors | |
| U Provides a global clearing system for tokenised deposits and stablecoins | Undisclosed | StrategicUndisclosed | Fintech | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1High-Tech Gründerfonds
TODAY, Finches, Kontext
38rounds4led - 2Antler
Boxd, Creem, Souk
23rounds0led - 3Y Combinator (YC)
Sensible Biotechnologies, Revnu, Spott
21rounds1led - 4General Catalyst
Complir, Integral, Intropy
20rounds1led - 5Index Ventures
Spiko, Nomos, Wonderful
19rounds2led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.